Revised Supplementary Data from TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer Article Swipe
María F. Mercogliano
,
Mara De Martino
,
Leandro Venturutti
,
Martín A. Rivas
,
Cecilia J. Proietti
,
Gloria Inurrigarro
,
Isabel Frahm
,
Daniel H. Allemand
,
Ernesto Gil Deza
,
Sandra Ares
,
Felipe G. Gercovich
,
Pablo Guzmán
,
Juan Carlos Roa
,
Patricia V. Elizalde
,
Roxana Schillaci
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22465458.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22465458.v1
Revised Supplementary Data
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.22465458.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361926783
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361926783Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.22465458.v1Digital Object Identifier
- Title
-
Revised Supplementary Data from TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast CancerWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
María F. Mercogliano, Mara De Martino, Leandro Venturutti, Martín A. Rivas, Cecilia J. Proietti, Gloria Inurrigarro, Isabel Frahm, Daniel H. Allemand, Ernesto Gil Deza, Sandra Ares, Felipe G. Gercovich, Pablo Guzmán, Juan Carlos Roa, Patricia V. Elizalde, Roxana SchillaciList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.22465458.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.22465458.v1Direct OA link when available
- Concepts
-
Trastuzumab, Breast cancer, Mucin, MUC1, Internal medicine, Tumor necrosis factor alpha, Cancer research, Oncology, Medicine, Cancer, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361926783 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.22465458.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.22465458.v1 |
| ids.openalex | https://openalex.org/W4361926783 |
| fwci | 0.0 |
| type | preprint |
| title | Revised Supplementary Data from TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10755 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9972000122070312 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | HER2/EGFR in Cancer Research |
| topics[1].id | https://openalex.org/T10602 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9934999942779541 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Glycosylation and Glycoproteins Research |
| topics[2].id | https://openalex.org/T11016 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9921000003814697 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2741 |
| topics[2].subfield.display_name | Radiology, Nuclear Medicine and Imaging |
| topics[2].display_name | Monoclonal and Polyclonal Antibodies Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779786085 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8862607479095459 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q412616 |
| concepts[0].display_name | Trastuzumab |
| concepts[1].id | https://openalex.org/C530470458 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6346848011016846 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[1].display_name | Breast cancer |
| concepts[2].id | https://openalex.org/C179264091 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6064513325691223 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q410862 |
| concepts[2].display_name | Mucin |
| concepts[3].id | https://openalex.org/C2777421810 |
| concepts[3].level | 3 |
| concepts[3].score | 0.4826262891292572 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q21145188 |
| concepts[3].display_name | MUC1 |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4456075131893158 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C17991360 |
| concepts[5].level | 2 |
| concepts[5].score | 0.44180071353912354 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q21173843 |
| concepts[5].display_name | Tumor necrosis factor alpha |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.4374251961708069 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.37751537561416626 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.37719425559043884 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.3271441161632538 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| concepts[10].id | https://openalex.org/C142724271 |
| concepts[10].level | 1 |
| concepts[10].score | 0.07618275284767151 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[10].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/trastuzumab |
| keywords[0].score | 0.8862607479095459 |
| keywords[0].display_name | Trastuzumab |
| keywords[1].id | https://openalex.org/keywords/breast-cancer |
| keywords[1].score | 0.6346848011016846 |
| keywords[1].display_name | Breast cancer |
| keywords[2].id | https://openalex.org/keywords/mucin |
| keywords[2].score | 0.6064513325691223 |
| keywords[2].display_name | Mucin |
| keywords[3].id | https://openalex.org/keywords/muc1 |
| keywords[3].score | 0.4826262891292572 |
| keywords[3].display_name | MUC1 |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.4456075131893158 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/tumor-necrosis-factor-alpha |
| keywords[5].score | 0.44180071353912354 |
| keywords[5].display_name | Tumor necrosis factor alpha |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.4374251961708069 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.37751537561416626 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.37719425559043884 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.3271441161632538 |
| keywords[9].display_name | Cancer |
| keywords[10].id | https://openalex.org/keywords/pathology |
| keywords[10].score | 0.07618275284767151 |
| keywords[10].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.22465458.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.22465458.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22465458 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Revised_Supplementary_Data_from_TNF_-Induced_Mucin_4_Expression_Elicits_Trastuzumab_Resistance_in_HER2-Positive_Breast_Cancer/22465458 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5062780805 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1094-9247 |
| authorships[0].author.display_name | María F. Mercogliano |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | María F. Mercogliano |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5038737665 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3049-6495 |
| authorships[1].author.display_name | Mara De Martino |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mara De Martino |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5011827252 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7264-8370 |
| authorships[2].author.display_name | Leandro Venturutti |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Leandro Venturutti |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5003931922 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9603-6897 |
| authorships[3].author.display_name | Martín A. Rivas |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Martín A. Rivas |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5039187562 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5875-4540 |
| authorships[4].author.display_name | Cecilia J. Proietti |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Cecilia J. Proietti |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5086989137 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Gloria Inurrigarro |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Gloria Inurrigarro |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5047036541 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Isabel Frahm |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Isabel Frahm |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5014295108 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Daniel H. Allemand |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Daniel H. Allemand |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5050321073 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Ernesto Gil Deza |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ernesto Gil Deza |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5007966369 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Sandra Ares |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Sandra Ares |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5054446752 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Felipe G. Gercovich |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Felipe G. Gercovich |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5030638354 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-5847-7248 |
| authorships[11].author.display_name | Pablo Guzmán |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Pablo Guzmán |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5050852442 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-8313-8774 |
| authorships[12].author.display_name | Juan Carlos Roa |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Juan C. Roa |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5003805715 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-5923-9898 |
| authorships[13].author.display_name | Patricia V. Elizalde |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Patricia V. Elizalde |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5073909973 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-7776-3378 |
| authorships[14].author.display_name | Roxana Schillaci |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | Roxana Schillaci |
| authorships[14].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.22465458.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Revised Supplementary Data from TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10755 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9972000122070312 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | HER2/EGFR in Cancer Research |
| related_works | https://openalex.org/W2593281753, https://openalex.org/W2060705043, https://openalex.org/W2088202934, https://openalex.org/W2094438822, https://openalex.org/W1984245894, https://openalex.org/W2046553400, https://openalex.org/W1987386449, https://openalex.org/W2086057929, https://openalex.org/W2045400462, https://openalex.org/W2064975714 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.22465458.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.22465458.v1 |
| primary_location.id | doi:10.1158/1078-0432.22465458.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.22465458.v1 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.Supplementary | 1 |
| abstract_inverted_index.Data</p> | 2 |
| abstract_inverted_index.<p>Revised | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 15 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5699999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.15265181 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |